AASLD	American Association for the Study of Liver Diseases
AH	Arterial Hypertension
CI	Confidence intervals
CIN	Contrast induced nephropathy
CKD	Chronic kidney disease
DAA	Direct-acting antiviral agent
DM	Diabetes mellitus
eGFR	Estimated glomerular filtration rate
ESRD	End-stage renal disease
GN	Glomerulonephritis
HBV	Hepatitis B virus
HCC	Hepatitis C virus
HCV	Hepatocellular carcinoma
HD	Hemodialysis
IDSA	Infectious Disease Society of America
IFN	Interferon
ITT	Incidence rate ratio
LT	Liver transplant
NA	Not available
OR	Odds ratio
PegIFN	Pegylated interferon
RBV	Ribavirin
RR	Relative risk
RT	Renal transplant
SOF	Sofosbuvir
SVR	Sustained Virological Response
W12	12 weeks after antiviral therapy ended